NEW HAVEN, Conn., Aug. 10 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. today announced the date and location of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which its lead oncology therapeutic Onrigin(TM) (laromustine) Injection will be presented.
